摘要
Abstract
Objective To explore the clinical efficacy of human immunoglobulin as an adjuvant therapy in the treat-ment of pediatric severe peumonia. Methods 80 children with severe pneumonia from June 2013 to November 2014 in our hospital were selected and randomly divided into the control group and the observation group,40 cases in each group.The control group was treated with conventional treatment including antibiotics,anti-virus,oxygen inhalation and heart failure correcting,the observation group was given human immunoglobulin as an adjuvant therapy on the basis of control group.The therapeutic effect in two groups was compared. Results The total effective rate in the observation group was higher than that in the control group,with significant difference (P<0.05).The time of fever subsidence,cough disappeared time,rales disappear time,X-ray examination inflammation absorption time and the total hospitalization time in the observation group was shorter than that in the control group,with significant difference (P<0.05).The level of serum IgG after treatment in the observation group was lower than that in the control group,with significant difference (P<0.05). Conclusion The effect of human immunoglobulin as an adjuvant therapy in the treatment of pediatric severe pneumonia is significant,which can effectively shorten the time of fever subsidence,cough disappeared time,rales disap-pear time,X-ray examination inflammation absorption time and the total hospitalization time,reduce serum IgG level,it is worthy of clinical promotion and application.关键词
人免疫球蛋白/小儿重症肺炎/临床疗效Key words
Human immunoglobulin/Pediatric severe pneumonia/Clinical efficacy分类
医药卫生
